Company Edge Therapeutics Inc Nasdaq
Equities
US2798701098
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 15/19/15 |
Director of Finance/CFO | 55 | 04/12 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Spencer Brown
CMP | Compliance Officer | 54 | 01/22/01 |
Gregory Conn
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/05/01 |
Joe J. Dervan
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Glover
CHM | Chairman | 60 | 02/19/02 |
Otis Brawley
BRD | Director/Board Member | 64 | 03/20/03 |
Richard Sykes
BRD | Director/Board Member | 79 | 01/19/01 |
Director/Board Member | 65 | 21/20/21 | |
Gregory Freitag
BRD | Director/Board Member | 62 | 01/19/01 |
Frank Bedu-Addo
FOU | Founder | 59 | 15/19/15 |
Ilian Iliev
BRD | Director/Board Member | 48 | 08/20/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,679,275 | 35,209,588 ( 95.99 %) | 0 | 95.99 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+7.52% | 11TCr | |
+11.38% | 11TCr | |
-12.64% | 2.22TCr | |
+0.44% | 2.13TCr | |
-4.18% | 1.9TCr | |
-37.85% | 1.85TCr | |
-8.58% | 1.68TCr | |
+37.41% | 1.25TCr | |
-23.95% | 808.97Cr |